Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo

Virology

Volumn 289, Issue 2, 2001, Pages 283-296

  Teng, Michael N ^a   Whitehead, Stephen S ^a   Collins, Peter L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN G;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN SECRETION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA VIRUS INFECTION; VERO CELL; VIROGENESIS; VIRUS ADSORPTION; VIRUS ATTENUATION; VIRUS MORPHOGENESIS; VIRUS NEUTRALIZATION; VIRUS PATHOGENESIS; VIRUS PLAQUE; VIRUS REPLICATION;

ANIMALIA; HUMAN RESPIRATORY SYNCYTIAL VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; STAPHYLOCOCCUS PHAGE 187; SYNCYTIAL VIRUS;

EID: 0035950607     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1138     Document Type: Article

References (40)

1. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription
2. Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replication in vitro and in vivo
3. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse
4. A highly efficient procedure for site-specific mutagenesis of full-length plasmids using Vent DNA polymerase
5. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence
6. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development
7. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus
8. Respiratory syncytial virus
9. Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: Altered O-glycosylation in the presence of brefeldin A
10. Animal cell mutants defective in glycosaminoglycan biosynthesis
11. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription
12. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate
13. Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G
14. Structure-function analysis of the Sendai virus F and HN cytoplasmic domain: Different role for the two proteins in the production of virus particle
15. Cytoplasmic inclusions of respiratory syncytial virus-infected cells: Formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein
16. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection
17. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection
18. The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription
19. Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus
20. Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents
21. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: Extensive sequence divergence between antigenically related proteins
22. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism
23. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge
24. The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein
25. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant
26. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells
27. Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor
28. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus
29. Sendai virus-like particles devoid of haemagglutinin-neuraminidase protein infect cells via the human asialoglycoprotein receptor
30. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization
31. RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation
32. The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons
33. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response
34. Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles
35. Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein
36. Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees
37. Monoclonal antibody neutralization escape mutants of respiratory syncytial virus with unique alterations in the attachment (G) protein
38. Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees
39. Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees
40. The cytoplasmic tails of the influenza virus spike glycoproteins are required for normal genome packaging